| Literature DB >> 32390102 |
Holger Gevensleben1, David Schmiedeke2, Hartmut Heinrich3,4,5,6, Aribert Rothenberger2.
Abstract
Neurofeedback training (NFT) provides strategies for children with ADHD to achieve changes on the neurophysiological and behavioral level to attenuate ADHD symptoms. We assume self-efficacy (an "active attitude"), a core variable in successful NFT. In a randomized, double-blind controlled study, we investigated the impact of a "placebo instruction" on the EEG-regulation performance during two sessions of Theta-Beta-NFT in children with ADHD (age 8-12 years). Children receiving the information "this might be a placebo-training" showed inferior neuroregulation (n = 10) compared to children receiving a standard instruction (n = 12). Results of our pilot study are discussed in view of factors necessary for a valid training (ensuring maximal self-efficacy in the participants) and the fidelity of placebo-controlled trials in NFT-research.Entities:
Keywords: Attention-deficit/hyperactivity disorder (ADHD); Neurofeedback; Neuroregulation; Placebo; Theta-beta-training
Year: 2020 PMID: 32390102 PMCID: PMC7293682 DOI: 10.1007/s00702-020-02193-z
Source DB: PubMed Journal: J Neural Transm (Vienna) ISSN: 0300-9564 Impact factor: 3.575
Demographic, behavioral, and EEG baseline characteristics of the self-control instruction group and the potential-placebo instruction group
| Self-control instruction ( | Potential-placebo instruction ( | Statistics | |
|---|---|---|---|
| Age (months) | 117.0 (15.6) | 111.6 (19.2) | |
| Sex (boys/girls) | 10/2 | 8/2 | |
| ADHD rating scale (FBB-ADHS; Döpfner et al. | |||
| Total score | 34.2 (13.2) | 31.5 (7.5) | |
| Inattention | 17.3 (5.3) | 19.3 (4.2) | |
| Hyperactivity/impulsivity | 17.3 (8.6) | 13.1 (5.9) | |
| Conduct Disorder Rating Scale (FBB-SSV; Döpfner et al. | |||
| Total score | 18.6 (8.3) | 16.8 (9.1) | |
| Strengths and Difficulties Questionnaire (SDQ; Woerner et al. | |||
| Total score | 16.8 (4.9) | 18.4 (5.8) | |
| EEG–baseline (µV) | |||
| Theta (session 1) | 3.30 (0.95) | 2.96 (0.66) | |
| Theta (session 2) | 3.34 (0.91) | 2.98 (0.50) | |
| Beta (session 1) | 1.36 (0.70) | 1.21 (0.24) | |
| Beta (session 2) | 1.33 (0.62) | 1.20 (0.20) | |
Mean values and standard deviations are listed for each group
For all statistical tests, p >0 .17
Fig. 1a Beta activity (referred to baseline, averaged over both sessions and all trials) is higher in the 'self-control instructions' group (SCI, orange) compared to the 'potentially placebo instructions' group (PPI, blue). b Theta activity in the second session (referred to baseline) shows a steeper decline in the SCI group (orange) compared to the PPI group (blue) over the course of the session. Means ± SE are depicted